MedicinoVa Files 2025 Proxy Statement

Ticker: MNOV · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1226616

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

MedicinoVa proxy filed, shareholder vote on directors & company matters coming June 17.

AI Summary

MedicinoVa, Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for its annual meeting scheduled for June 17, 2025. The filing provides details regarding the company's governance and shareholder matters, including information relevant to the election of directors and other corporate actions to be voted on by shareholders.

Why It Matters

This filing outlines the key proposals and director nominations shareholders will vote on, impacting the company's future direction and leadership.

Risk Assessment

Risk Level: low — This is a routine annual filing providing information to shareholders and does not indicate any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions.

When is MedicinoVa's annual meeting scheduled?

MedicinoVa's annual meeting is scheduled for June 17, 2025.

What is the filing date of this proxy statement?

This definitive proxy statement was filed on April 28, 2025.

Who is the registrant for this filing?

The registrant for this filing is MEDICINOVA, INC.

What is the SIC code for MedicinoVa?

The Standard Industrial Classification (SIC) code for MedicinoVa is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding MEDICINOVA INC (MNOV).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing